Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in the Company's compounding facilities; the Fagron Trademarks segment encompasses concepts and formulations developed by the Company's research and development (R&D) team; Fagron Essentials comprises pharmaceutical raw materials, equipment and supplies for pharmacies, and the HL Technology segment includes the development and production of precision components and orthopedic tools for dental and medical professionals.
Metrics to compare | FAGRO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFAGROPeersSector | |
---|---|---|---|---|
P/E Ratio | 17.4x | 18.5x | −0.6x | |
PEG Ratio | 1.14 | 0.25 | 0.00 | |
Price/Book | 2.9x | 2.4x | 2.6x | |
Price / LTM Sales | 1.7x | 0.6x | 3.2x | |
Upside (Analyst Target) | 21.4% | 12.2% | 46.9% | |
Fair Value Upside | Unlock | 19.8% | 7.9% | Unlock |